Adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer: a multicenter randomized clinical trial in Japan. (September 2018) - Hirano, S.; Ebata, T.; Konishi, M.; Uesaka, K.; Tsuchiya, Y.; Ohtsuka, M.; Fukutomi, A.; Ando, M.; Nimura, Y.; Nagino, M.; ,